Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
Both micro and macro impacts for life settlement market but counterparty fundamentals remain strong.
For life settlement markets, earlier diagnosis of chronic diseases may reduce projected life expectancy, thereby influencing the expected duration of premium payments and the timing of policy maturities.
The transaction, completed in March 2026, secures the benefits of 16 deferred and 24 pensioner members of the scheme and completes the buy-in of all scheme liabilities.
The equity release market recorded a slowdown in Q1 2026, as global uncertainty weighed on consumer decision-making and delayed completions, according to new data from UK industry group the Equity Release Council.
160m bulk purchase annuity buy-in was completed in March 2026 and secures the pension benefits for all 2,216 of the scheme’s members, comprising 1,108 members with pensions in payment and 1,108 deferred members.
CMT will use the proceeds of this issue to refinance outstanding indebtedness, acquire mortgages originated by HomeEquity Bank, and to fund ongoing operations.
Funded reinsurance transactions involving UK life insurers will face enhanced regulatory requirements under new proposals unveiled today by the Prudential Regulation Authority.
There are new rules around surplus extraction as well as a permanent regime for the superfund market which could impact the DB pension de-risking market going forward.
£11m bulk purchase annuity buy-in with Just Group. The deal secures the benefits for 147 scheme members.
The total number of life insurance policies purchased in the life settlement industry’s secondary market grew 10.2% from 2,697 in 2024 to 2,972 in 2025, according to new data published by life settlement provider, Coventry.